PROPANC BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
PROPANC BIOPHARMA, INC. (PPCB) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 0 shares as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-05-14
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 0.00 shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 0.00 shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 0.00 shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 0.00 shares S-1 · filed 2026-04-10 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 0.00 shares S-1 · filed 2026-04-10 |
| 2024-09-30 | 0.06 shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 0.06 shares 10-K · filed 2024-09-30 |
| 2024-03-31 | 0.06 shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 0.06 shares 10-Q · filed 2024-02-20 |
| 2023-09-30 | 0.06 shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 0.06 shares 10-K · filed 2023-09-28 |
| 2023-03-31 | 59.00 shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 59.00 shares 10-Q · filed 2023-02-10 |
| 2022-09-30 | 59.00 shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 59.00 shares 10-K · filed 2022-09-28 |
| 2022-03-31 | 39.00 shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 39.00 shares 10-Q · filed 2022-02-14 |
| 2021-09-30 | 39.00 shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 40.00 shares 10-K · filed 2021-09-28 |
| 2021-03-31 | 21.00 shares 10-Q · filed 2021-05-14 |
| 2020-12-31 | 21.00 shares 10-Q · filed 2021-02-12 |
| 2020-09-30 | 20.64K shares 10-Q · filed 2020-11-16 |
| 2020-06-30 | 20.64K shares 10-K · filed 2020-10-01 |
| 2019-06-30 | 1.14K shares 10-K · filed 2019-10-15 |
| 2018-06-30 | 572.00K shares 10-K · filed 2018-09-17 |
| 2016-06-30 | 47.67M shares 10-K · filed 2016-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |